Literature DB >> 19834779

Abnormal morphology of peripheral cell tissues from patients with Huntington disease.

Ferdinando Squitieri1, Alessandra Falleni, Milena Cannella, Sara Orobello, Federica Fulceri, Paola Lenzi, Francesco Fornai.   

Abstract

We investigated the genotype-dependency of morphological abnormalities in peripheral cells from Huntington disease (HD) patients. Cell cultures derived from skin and muscle biopsies showed a different set of abnormalities depending on the genotype (i.e. heterozygous and homozygous for CAG mutations) and the tissue (i.e. fibroblasts and myoblasts). In general, homozygotes' cell lines showed massive ultrastructural damage of specific cell organelles compared with age matched control. These consist of vacuolization, deranged crests and matrix found within giant mitochondria. In addition, enlarged endoplasmic reticulum and the occurrence of numerous autophagic vacuoles, which were similar to those occurring in neurons within affected brain areas, were described. Despite a comparable dose-dependency on mitochondrial changes, this kind of alterations differ in fibroblasts compared with myoblasts. In fact, the internal mitochondrial structure was merely lost in myoblasts, while it shows pathological re-organization within fibroblasts, where altered crests appear as multilamellar circles. These data indicate that ultrastructural abnormalities from peripheral tissues of HD patients can be used as potential disease markers which are easier to get than autoptic brains. Moreover, the occurrence of ultrastructural cell pathology reminiscent of neuronal degeneration in HD, suggests the use of human peripheral cells as a tool to investigate the pathogenic cascade subsequent to huntingtin dysregulation.

Entities:  

Mesh:

Year:  2009        PMID: 19834779     DOI: 10.1007/s00702-009-0328-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  28 in total

Review 1.  Autophagy and human disease.

Authors:  Ju Huang; Daniel J Klionsky
Journal:  Cell Cycle       Date:  2007-05-25       Impact factor: 4.534

2.  Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice.

Authors:  Zemfira Z Gizatullina; Katrin S Lindenberg; Phoebe Harjes; Ying Chen; Christoph M Kosinski; Bernhard G Landwehrmeyer; Albert C Ludolph; Frank Striggow; Stephan Zierz; Frank N Gellerich
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

Review 3.  Oxidative damage in Huntington's disease pathogenesis.

Authors:  Susan E Browne; M Flint Beal
Journal:  Antioxid Redox Signal       Date:  2006 Nov-Dec       Impact factor: 8.401

4.  Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy.

Authors:  R Lodi; A H Schapira; D Manners; P Styles; N W Wood; D J Taylor; T T Warner
Journal:  Ann Neurol       Date:  2000-07       Impact factor: 10.422

5.  Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.

Authors:  Carsten Saft; Jochen Zange; Jürgen Andrich; Klaus Müller; Katrin Lindenberg; Bernhard Landwehrmeyer; Matthias Vorgerd; Peter H Kraus; Horst Przuntek; Ludger Schöls
Journal:  Mov Disord       Date:  2005-06       Impact factor: 10.338

Review 6.  Mitochondrial structural and functional dynamics in Huntington's disease.

Authors:  P Hemachandra Reddy; Peizhong Mao; Maria Manczak
Journal:  Brain Res Rev       Date:  2009-04-24

7.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

8.  Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.

Authors:  Zhao-Xue Yu; Shi-Hua Li; Joy Evans; Ajay Pillarisetti; He Li; Xiao-Jiang Li
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

9.  Impaired PGC-1alpha function in muscle in Huntington's disease.

Authors:  Rajnish K Chaturvedi; Peter Adhihetty; Shubha Shukla; Thomas Hennessy; Noel Calingasan; Lichuan Yang; Anatoly Starkov; Mahmoud Kiaei; Milena Cannella; Jenny Sassone; Andrea Ciammola; Fernando Squitieri; M Flint Beal
Journal:  Hum Mol Genet       Date:  2009-05-21       Impact factor: 6.150

10.  Quantitative characterization of dense body, autophagic vacuole, and acid phosphatase-bearing particle populations during the early phases of glucagon-induced autophagy in rat liver.

Authors:  R L Deter
Journal:  J Cell Biol       Date:  1971-03       Impact factor: 10.539

View more
  29 in total

1.  Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells.

Authors:  Ferdinando Squitieri; Vittorio Maglione; Sara Orobello; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2011-04-26       Impact factor: 3.575

2.  Key role of nuclear medicine in seeking biomarkers of Huntington's disease.

Authors:  Ferdinando Squitieri; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 9.236

Review 3.  The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  Mech Ageing Dev       Date:  2016-09-12       Impact factor: 5.432

Review 4.  Shaping the role of mitochondria in the pathogenesis of Huntington's disease.

Authors:  Veronica Costa; Luca Scorrano
Journal:  EMBO J       Date:  2012-03-23       Impact factor: 11.598

Review 5.  Mitochondrial dynamic changes in health and genetic diseases.

Authors:  Le Chen; Allison J Winger; Anne A Knowlton
Journal:  Mol Biol Rep       Date:  2014-11       Impact factor: 2.316

Review 6.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

7.  Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.

Authors:  Ulziibat Shirendeb; Arubala P Reddy; Maria Manczak; Marcus J Calkins; Peizhong Mao; Danilo A Tagle; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2011-01-21       Impact factor: 6.150

8.  Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6/2 mice, a model of Huntington's disease.

Authors:  James Hamilton; Jessica J Pellman; Tatiana Brustovetsky; Robert A Harris; Nickolay Brustovetsky
Journal:  Hum Mol Genet       Date:  2016-04-30       Impact factor: 6.150

Review 9.  Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.

Authors:  Sylvette Ayala-Peña
Journal:  Free Radic Biol Med       Date:  2013-04-18       Impact factor: 7.376

10.  Deterministic Absolute Negative Mobility for Micro- and Submicrometer Particles Induced in a Microfluidic Device.

Authors:  Jinghui Luo; Katherine A Muratore; Edgar A Arriaga; Alexandra Ros
Journal:  Anal Chem       Date:  2016-05-17       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.